METACARD MR Tablet
Metacard MR Tablet is a metabolic treatment for ischaemic heart disease. It can be used at all stages of angina pectoris and in post myocardial infarction. Metacard MR therapy has also demonstrated beneficial effects when administered during bypass surgery.
Trimetazidine BP 35 mg (Modified release tablet)
Each box contains 70's tablets in blister pack.
Dosage & Administration
One tablet at mealtimes in the morning and evening.
Trimetazidine is contraindicated in-patients with a known hypersensitivity to its components.
Trimetazidine is safe and well tolerated. Rare cases of gastrointestinal disorders, nausea & vomiting have been reported.
No drug interactions so far have been reported. In particular, no interactions have been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidaemic agents or digitalis preparation.